Body composition and breast cancer risk and treatment: mechanisms and impact Toshiaki IwaseXiaoping WangNaoto T. Ueno Review 21 January 2021 Pages: 273 - 283
Meta-analysis and cost-effectiveness of ductoscopy, duct excision surgery and MRI for the diagnosis and treatment of patients with pathological nipple discharge M. D. FilipeS. I. S. PatuleiaA. J. Witkamp Review Open access 21 January 2021 Pages: 285 - 293
Heart failure prevention and monitoring strategies in HER2-positive breast cancer: a narrative review Lua JafariNausheen Akhter Review 22 January 2021 Pages: 295 - 303
Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-/PR- breast cancer cells Elena E. TzekakiGeorge GeromichalosAngelos Papaspyropoulos Preclinical study 03 January 2021 Pages: 305 - 316
FOXA1 is a determinant of drug resistance in breast cancer cells Uttom KumarAnastasia ArdashevaErnesto Yagüe Preclinical study Open access 08 January 2021 Pages: 317 - 326
Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients Peng QiYu YangXiao-yan Zhou Preclinical study Open access 13 January 2021 Pages: 327 - 342
Can we rely on surgical clips placed during oncoplastic breast surgery to accurately delineate the tumor bed for targeted breast radiotherapy? Ghada AldosaryJean-Michel CaudrelierEric Vandervoort Preclinical study 23 January 2021 Pages: 343 - 352
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development Ayako NakashojiTetsu HayashidaYuko Kitagawa Preclinical study 18 January 2021 Pages: 353 - 361
Heregulin-induced cell migration is prevented by trastuzumab and trastuzumab-emtansine in HER2+ breast cancer Joselina Magali MondacaAna Carla Castro GuijarroAngel Matias Sanchez Preclinical study 20 January 2021 Pages: 363 - 377
Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients David W. DodingtonAndrew LagreeFang-I Lu Preclinical study 23 January 2021 Pages: 379 - 389
Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry Evelyn M. JiaggePeter J. UlintzSofia D. Merajver Preclinical study 12 February 2021 Pages: 391 - 401
Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast Libo YangMadhuchhanda RoyYun Wu Preclinical study 02 February 2021 Pages: 403 - 415
Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials Matthew P. GoetzMeena OkeraGeorge W. Sledge Jr. Clinical trial Open access 03 January 2021 Pages: 417 - 428
Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation Molly B. MoravekRafael ConfinoMary Ellen Pavone Clinical trial 04 January 2021 Pages: 429 - 437
CTCs-oriented adjuvant personalized cytostatic therapy non-metastatic breast cancer patients: continuous non-randomized prospective study and prospective randomized controlled study Ya A. Shliakhtunou Clinical trial Open access 03 January 2021 Pages: 439 - 451
New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12) Jae Sik KimKyubo KimIn Ah Kim Clinical trial 04 January 2021 Pages: 453 - 462
Prediction of axillary nodal burden in patients with invasive lobular carcinoma using MRI Su Min HaJung Min ChangWoo Kyung Moon Clinical trial 03 January 2021 Pages: 463 - 473
Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature Ching-Shui HuangTzu-Pin LuChi-Cheng Huang Clinical trial 03 January 2021 Pages: 475 - 485
Myosteatosis evaluation using erector spinae and psoas muscles to predict adverse events during adjuvant chemotherapy for breast cancer G. F. P. AleixoH. YuG. R. Williams Clinical trial 10 January 2021 Pages: 487 - 495
International variation in breast cancer incidence and mortality in young women Victoria Sopik Epidemiology 03 November 2020 Pages: 497 - 507
Patterns of de-novo metastasis and breast cancer-specific mortality by race and molecular subtype in the SEER population-based dataset Swati SakhujaApril DeveauxTomi Akinyemiju Epidemiology 11 November 2020 Pages: 509 - 518
COVID-19 and breast cancer at a Regional Breast Centre: our flexible approach during the pandemic Lina CadiliKristin DeGirolamoRebecca Warburton Epidemiology 04 November 2020 Pages: 519 - 525
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach Andrea P. DaminMaira ZancanJorge V. Biazus Epidemiology 09 November 2020 Pages: 527 - 534
Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer Ipshita PrakashSamantha M. ThomasOluwadamilola M. Fayanju Epidemiology 18 November 2020 Pages: 535 - 550
Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes Sasha R. HalaszThomas O’KeefeSarah L. Blair Epidemiology 12 November 2020 Pages: 551 - 559
Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer Eric XieMaya M. LapinskiCesar A. Santa-Maria Epidemiology 13 November 2020 Pages: 561 - 568
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series Jasmine SukumarMahmoud KassemSagar Sardesai Brief Report Open access 28 January 2021 Pages: 569 - 575
(Ex-)breast cancer patients with (pre-existing) symptoms of anxiety and/or depression experience higher barriers to contact health care providers during the COVID-19 pandemic Dieuwke R. Mink van der MolenClaudia A. BargonUMBRELLA study group Brief Report Open access 18 February 2021 Pages: 577 - 583
RE: Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early stage breast cancer patients Xiao‑Min LiHong-Lin Chen Letter to the Editor 11 March 2021 Pages: 585 - 586
Correction to: Behavior of metastatic breast cancer according to subtype Margot Van MechelenAnke Van HerckHans Wildiers Correction 07 January 2021 Pages: 587 - 589